Cargando…
Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide
Graphene oxide (GO) is increasingly used for controlling mass diffusion in hydrogel-based drug delivery applications. On the macro-scale, the density of GO in the hydrogel is a critical parameter for modulating drug release. Here, we investigate the diffusion of a peptide drug through a network of G...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832740/ https://www.ncbi.nlm.nih.gov/pubmed/29445040 http://dx.doi.org/10.1098/rsif.2017.0949 |
_version_ | 1783303353617350656 |
---|---|
author | Puvirajesinghe, T. M. Zhi, Z. L. Craster, R. V. Guenneau, S. |
author_facet | Puvirajesinghe, T. M. Zhi, Z. L. Craster, R. V. Guenneau, S. |
author_sort | Puvirajesinghe, T. M. |
collection | PubMed |
description | Graphene oxide (GO) is increasingly used for controlling mass diffusion in hydrogel-based drug delivery applications. On the macro-scale, the density of GO in the hydrogel is a critical parameter for modulating drug release. Here, we investigate the diffusion of a peptide drug through a network of GO membranes and GO-embedded hydrogels, modelled as porous matrices resembling both laminated and ‘house of cards’ structures. Our experiments use a therapeutic peptide and show a tunable nonlinear dependence of the peptide concentration upon time. We establish models using numerical simulations with a diffusion equation accounting for the photo-thermal degradation of fluorophores and an effective percolation model to simulate the experimental data. The modelling yields an interpretation of the control of drug diffusion through GO membranes, which is extended to the diffusion of the peptide in GO-embedded agarose hydrogels. Varying the density of micron-sized GO flakes allows for fine control of the drug diffusion. We further show that both GO density and size influence the drug release rate. The ability to tune the density of hydrogel-like GO membranes to control drug release rates has exciting implications to offer guidelines for tailoring drug release rates in hydrogel-based therapeutic delivery applications. |
format | Online Article Text |
id | pubmed-5832740 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Royal Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-58327402018-03-05 Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide Puvirajesinghe, T. M. Zhi, Z. L. Craster, R. V. Guenneau, S. J R Soc Interface Life Sciences–Physics interface Graphene oxide (GO) is increasingly used for controlling mass diffusion in hydrogel-based drug delivery applications. On the macro-scale, the density of GO in the hydrogel is a critical parameter for modulating drug release. Here, we investigate the diffusion of a peptide drug through a network of GO membranes and GO-embedded hydrogels, modelled as porous matrices resembling both laminated and ‘house of cards’ structures. Our experiments use a therapeutic peptide and show a tunable nonlinear dependence of the peptide concentration upon time. We establish models using numerical simulations with a diffusion equation accounting for the photo-thermal degradation of fluorophores and an effective percolation model to simulate the experimental data. The modelling yields an interpretation of the control of drug diffusion through GO membranes, which is extended to the diffusion of the peptide in GO-embedded agarose hydrogels. Varying the density of micron-sized GO flakes allows for fine control of the drug diffusion. We further show that both GO density and size influence the drug release rate. The ability to tune the density of hydrogel-like GO membranes to control drug release rates has exciting implications to offer guidelines for tailoring drug release rates in hydrogel-based therapeutic delivery applications. The Royal Society 2018-02 2018-02-14 /pmc/articles/PMC5832740/ /pubmed/29445040 http://dx.doi.org/10.1098/rsif.2017.0949 Text en © 2018 The Authors. http://creativecommons.org/licenses/by/4.0/ Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. |
spellingShingle | Life Sciences–Physics interface Puvirajesinghe, T. M. Zhi, Z. L. Craster, R. V. Guenneau, S. Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
title | Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
title_full | Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
title_fullStr | Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
title_full_unstemmed | Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
title_short | Tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
title_sort | tailoring drug release rates in hydrogel-based therapeutic delivery applications using graphene oxide |
topic | Life Sciences–Physics interface |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832740/ https://www.ncbi.nlm.nih.gov/pubmed/29445040 http://dx.doi.org/10.1098/rsif.2017.0949 |
work_keys_str_mv | AT puvirajesinghetm tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide AT zhizl tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide AT crasterrv tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide AT guenneaus tailoringdrugreleaseratesinhydrogelbasedtherapeuticdeliveryapplicationsusinggrapheneoxide |